Sign In
Buy MDWD
$14.12
+0.0200 (+0.142%)
At Close: Jul 31, 2026
MediWound (MDWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
11:06am, Wednesday, 07'th Aug 2024
MediWound (MDWD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)
07:30am, Monday, 05'th Aug 2024
NEXT Confirms NexoBrid's Proven Safety and Efficacy in Eschar Removal, Significantly Reducing Surgical Procedures for Burn Patients NEXT Confirms NexoBrid's Proven Safety and Efficacy in Eschar Remova
MediWound to Report Second Quarter 2024 Financial Results
08:00am, Friday, 02'nd Aug 2024
Conference Call and Webcast Scheduled for Wednesday, August 14th at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Wednesday, August 14th at 8:30 am Eastern Time
Can MediWound (MDWD) Climb 57.49% to Reach the Level Wall Street Analysts Expect?
10:56am, Wednesday, 31'st Jul 2024
The consensus price target hints at a 57.5% upside potential for MediWound (MDWD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimat
MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
08:00am, Monday, 29'th Jul 2024
Research Published in THE LANCET's eClinicalMedicine EscharEx ® Outperforms Non-Surgical Standard of Care in Debridement and Promotion of Healthy Granulation Tissue
MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
07:30am, Tuesday, 16'th Jul 2024
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs)
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd
07:32am, Monday, 15'th Jul 2024
GOTHENBURG, Sweden , July 15, 2024 /PRNewswire/ -- Mölnlycke Health Care, a world-leading MedTech company specialising in solutions for wound care and surgical procedures, announced today an investme
MediWound Announces $25 Million Strategic Private Placement Financing
07:00am, Monday, 15'th Jul 2024
Mölnlycke Health Care, a global leader in innovative wound care solutions, leads the PIPE with a $15 million investment Mölnlycke Health Care, a global leader in innovative wound care solutions, lea
MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript
11:35am, Wednesday, 29'th May 2024
MediWound Ltd. (NASDAQ:MDWD ) Q1 2024 Earnings Conference Call May 29, 2024 8:30 AM ET Company Participants Ofer Gonen - Chief Executive Officer Hani Luxenburg - Chief Financial Officer Barry Wolfenso
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
09:16am, Wednesday, 29'th May 2024
MediWound (MDWD) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.44 per share a year ago.
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
07:00am, Wednesday, 29'th May 2024
NexoBrid® interest surges; $5 million in Q1 2024 revenue, with $24 million forecast for the year Manufacturing facility on target for completion by mid-2024 EscharEx® Phase III study to launch 2H 20
MediWound to Report First Quarter 2024 Financial Results
08:00am, Wednesday, 22'nd May 2024
Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern Time
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
08:00am, Thursday, 25'th Apr 2024
Oral presentations include additional comparative data between EscharEx ® and SANTYL ® , and new analyses show strong correlation between wound bed preparation and wound healing
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
08:26am, Wednesday, 17'th Apr 2024
MediWound (MDWD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?
10:56am, Monday, 25'th Mar 2024
The mean of analysts' price targets for MediWound (MDWD) points to a 76.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys
